StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) KPIs and segments

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.48+0.05 (+0.78%)

Close on Nov 17, 2026Market cap $110.85MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Atrium Therapeutics's business

Coming soon

This tab will track the numbers specific to Atrium Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?